Markus Friedrich

Evidence‐based (S3) guidelines for the treatment of psoriasis vulgaris

Alexander Nast, I. Kopp, Matthias Augustin et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2007 · 95 citations

Medicine, Dermatology, Pharmacotherapy +10

Immunomodulation by Interleukin-10 Therapy Decreases the Incidence of Relapse and Prolongs the Relapse-free Interval in Psoriasis

Markus Friedrich, Wolf‐Dietrich Döcke, Anja Klein et al. · Journal of Investigative Dermatology · 2002 · 80 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Effects of Systemic Interleukin-10 Therapy on Psoriatic Skin Lesions: Histologic, Immunohistologic, and Molecular Biology Findings

Khusru Asadullah, Markus Friedrich, S. Hanneken et al. · Journal of Investigative Dermatology · 2001 · 77 citations · Full text

Medicine, Dermatology, Immunology +16

Demonstration of Frequent Occurrence of Clonal T Cells in the Peripheral Blood But Not in the Skin of Patients With Small Plaque Parapsoriasis

J. Marcus Muche, Ansgar Lukowsky, Jürgen Heim et al. · Blood · 1999 · 56 citations

Medicine, Dermatology, Immunology +12

Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasis

Wolf‐Dietrich Döcke, Khusru Asadullah, G Belbe et al. · Journal of Leukocyte Biology · 2008 · 36 citations

Life Sciences, Dermatology, Immunology +17